跳至主要内容
临床试验/JPRN-UMIN000001011
JPRN-UMIN000001011未知未知

The efficacy and safety of 2.5% testosterone gel for late-onset hypogonadsism patients evaluated by using salivary testosterone. - The efficacy of 2.5% testosterone gel for late-onset hypogonadsism patients

Teikyo University, School of Medicine0 个研究点目标入组 15 人开始时间: 2008年2月10日最近更新:

试验速览

阶段
未知
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 90years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • Patients having serious heart, iver, and renal dysfunction. Pasients who have serious pshychiatric problems are also excluded.

研究者

发起方
Teikyo University, School of Medicine

相似试验

已完成
4 期
The efficacy of testosterone gel application for increases the sperm concentration in infertile men with oligospermia and low serum testosterone level
TCTR20161030001Faculty of Medicine, Siriraj Hospital16
已完成
4 期
The effects of testosterone gel administration in ARTinfertility.Female infertility associated with anovulation
IRCT201505197513N11Isfahan University of Medical Sciences64
进行中(未招募)
不适用
Endocrine study on the effects of testosterone gel application in male athletesThere will not be any special medical condition under investigation.Only healthy volunteers will be included in this clinical trial.
EUCTR2005-001453-22-DEGerman Sport University Cologne, Institute of CArdiology and Sports Medicine16
已完成
2 期
The effect of transdermal testosterone gel300mcg daily on cognitive performance in older postmenopausal women: a placebo controlled trial over 26 weekscognition in older postmenopausal womenMental Health - Studies of normal psychology, cognitive function and behaviour
ACTRN12609000981224Monash University120
招募中
3 期
The efficacy and safety of 0.5% topical timolol on corneometry and transepidermal water loss after ablative fractional CO2 laser for atrophic acne scars: a split face randomized double blind placebo-controlled trialWe considered that timolol may have an effect in wound healing promotion in patients who undergo AFCO2 resurfacing. Our study aimed to investigate the efficacy and safety of 0.5% topical timolol malea
TCTR20190722005none25